Oxcarbazepine (BioDeep_00000001507)

 

Secondary id: BioDeep_00000398888

human metabolite blood metabolite Chemicals and Drugs


代谢物信息卡片


9-oxo-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboxamide

化学式: C15H12N2O2 (252.0899)
中文名称: 奥卡西平
谱图信息: 最多检出来源 Homo sapiens(blood) 34.1%

Reviewed

Last reviewed on 2024-09-14.

Cite this Page

Oxcarbazepine. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China. https://query.biodeep.cn/s/oxcarbazepine (retrieved 2024-12-22) (BioDeep RN: BioDeep_00000001507). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

分子结构信息

SMILES: C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
InChI: InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)

描述信息

Oxcarbazepine is structurally a derivative of carbamazepine, adding an extra oxygen atom to the benzylcarboxamide group. This difference helps reduce the impact on the liver of metabolizing the drug, and also prevents the serious forms of anemia occasionally associated with carbamazepine. Aside from this reduction in side effects, it is thought to have the same mechanism as carbamazepine - sodium channel inhibition - and is generally used to treat partial seizures in epileptic children and adults.
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers
N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AF - Carboxamide derivatives
D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
D049990 - Membrane Transport Modulators

同义名列表

12 个代谢物同义名

9-oxo-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide; Novartis brand OF oxcarbazepine; Desitin brand OF oxcarbazepine; Oxcarbamazepine; Oxcarbazepinum; Oxcarbazepina; OXCARBAZEPINE; Trileptal; Oxtellar; Timox; Oxcarbazepine



数据库引用编号

17 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

1 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(1)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 6 ABCB1, AXIN2, BGLAP, CASP3, CYP2C19, CYP3A4
Peripheral membrane protein 1 CYP1B1
Endosome membrane 2 HLA-A, HLA-B
Endoplasmic reticulum membrane 7 CYP1B1, CYP2C19, CYP3A4, HLA-A, HLA-B, UGT1A9, UGT2B7
Nucleus 2 AXIN2, CASP3
cytosol 3 AVP, AXIN2, CASP3
dendrite 2 AVP, BGLAP
nuclear body 1 SCN1A
centrosome 1 AXIN2
nucleoplasm 3 CASP3, SCN1A, SCNN1G
Cell membrane 6 ABCB1, HLA-A, HLA-B, PRRT2, SCN1A, SCN2A
Cell projection, axon 1 PRRT2
Early endosome membrane 2 HLA-A, HLA-B
Multi-pass membrane protein 5 ABCB1, CACNA1I, SCN1A, SCN2A, SCNN1G
Synapse 1 PRRT2
cell surface 3 ABCB1, HLA-A, HLA-B
glutamatergic synapse 3 CASP3, PRRT2, SCN2A
Golgi apparatus 2 HLA-A, HLA-B
Golgi membrane 3 HLA-A, HLA-B, INS
lysosomal membrane 2 HLA-A, HLA-B
neuronal cell body 2 CASP3, SCN1A
presynaptic membrane 2 PRRT2, SCN2A
synaptic vesicle 1 PRRT2
Presynapse 1 PRRT2
plasma membrane 10 ABCB1, AXIN2, CACNA1I, CYP2C19, HLA-A, HLA-B, PRRT2, SCN1A, SCN2A, SCNN1G
synaptic vesicle membrane 1 PRRT2
Membrane 11 ABCB1, CACNA1I, CYP1B1, CYP3A4, HLA-A, HLA-B, PRRT2, SCN1A, SCN2A, UGT1A9, UGT2B7
apical plasma membrane 2 ABCB1, SCNN1G
axon 1 SCN2A
extracellular exosome 5 ABCB1, HLA-A, HLA-B, SCNN1G, SHBG
Lysosome membrane 2 HLA-A, HLA-B
endoplasmic reticulum 3 HLA-A, HLA-B, UGT1A9
extracellular space 6 AVP, BGLAP, HLA-A, HLA-B, INS, PTH
intercalated disc 2 SCN1A, SCN2A
mitochondrion 1 CYP1B1
intracellular membrane-bounded organelle 3 CYP1B1, CYP2C19, CYP3A4
Microsome membrane 2 CYP1B1, CYP3A4
postsynaptic density 1 CASP3
Single-pass type I membrane protein 2 HLA-A, HLA-B
Secreted 4 AVP, BGLAP, INS, SHBG
extracellular region 5 AVP, BGLAP, INS, PTH, SHBG
Single-pass membrane protein 5 HLA-A, HLA-B, PRRT2, UGT1A9, UGT2B7
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane 1 PRRT2
external side of plasma membrane 3 HLA-A, HLA-B, SCNN1G
dendritic spine 1 PRRT2
T-tubule 2 SCN1A, SCN2A
perikaryon 1 BGLAP
Z disc 1 SCN1A
beta-catenin destruction complex 1 AXIN2
vesicle 2 BGLAP, PRRT2
Apical cell membrane 2 ABCB1, SCNN1G
Cell projection, dendritic spine 1 PRRT2
secretory granule 1 AVP
phagocytic vesicle membrane 2 HLA-A, HLA-B
Recycling endosome membrane 2 HLA-A, HLA-B
endosome lumen 1 INS
sodium channel complex 1 SCNN1G
axon initial segment 1 SCN1A
Presynaptic cell membrane 1 PRRT2
secretory granule lumen 1 INS
secretory granule membrane 1 HLA-B
Golgi lumen 2 BGLAP, INS
endoplasmic reticulum lumen 2 BGLAP, INS
axon terminus 1 PRRT2
voltage-gated calcium channel complex 1 CACNA1I
transport vesicle 1 INS
node of Ranvier 2 SCN1A, SCN2A
paranode region of axon 1 SCN2A
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 INS
endoplasmic reticulum exit site 1 HLA-A
postsynaptic density membrane 1 PRRT2
neuronal dense core vesicle 1 AVP
ER to Golgi transport vesicle membrane 2 HLA-A, HLA-B
clathrin-coated endocytic vesicle membrane 1 AVP
external side of apical plasma membrane 1 ABCB1
death-inducing signaling complex 1 CASP3
lumenal side of endoplasmic reticulum membrane 2 HLA-A, HLA-B
MHC class I peptide loading complex 1 HLA-A
voltage-gated sodium channel complex 2 SCN1A, SCN2A
Golgi medial cisterna 1 HLA-A
MHC class I protein complex 2 HLA-A, HLA-B
MHC class II protein complex 2 HLA-A, HLA-B


文献列表

  • Julija Čiauškaitė, Giedrė Gelžinienė, Giedrė Jurkevičienė. Oxcarbazepine and Hyponatremia. Medicina (Kaunas, Lithuania). 2022 Apr; 58(5):. doi: 10.3390/medicina58050559. [PMID: 35629976]
  • Page B Pennell, Ashwin Karanam, Kimford J Meador, Elizabeth Gerard, Laura Kalayjian, Patricia Penovich, Abigail Matthews, Thomas M McElrath, Angela K Birnbaum. Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study. JAMA neurology. 2022 04; 79(4):370-379. doi: 10.1001/jamaneurol.2021.5487. [PMID: 35157004]
  • Ahmet Burak Dirim, Safak Mirioglu, Nilufer Yesilot, Emin Oguz, Halil Yazici, Murat Inanc, Bahar Artim-Esen. Chronic oxcarbazepine intoxication in a patient with primary antiphospholipid syndrome on maintenance haemodialysis. Journal of clinical pharmacy and therapeutics. 2022 Feb; 47(2):257-259. doi: 10.1111/jcpt.13504. [PMID: 34322888]
  • Momoka Ota, Takeshi Funakoshi, Toshihiko Aki, Kana Unuma, Koichi Uemura. Oxcarbazepine induces mitotic catastrophe and apoptosis in NRK-52E proximal tubular cells. Toxicology letters. 2021 Oct; 350(?):240-248. doi: 10.1016/j.toxlet.2021.07.018. [PMID: 34333065]
  • Ana Ferreira, Márcio Rodrigues, Sara Meirinho, Ana Fortuna, Amílcar Falcão, Gilberto Alves. Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats. Drug and chemical toxicology. 2021 Sep; 44(5):458-469. doi: 10.1080/01480545.2019.1601736. [PMID: 31020859]
  • G Vartzelis, A Attilakos, C Tsentidis, I Kalimeraki, D Maritsi, A Marmarinos, A Garoufi. Plasma brain natriuretic peptide levels in children with idiopathic epilepsy treated with longterm sodium valproate and oxcarbazepine monotherapy. Journal of biological regulators and homeostatic agents. 2021 Aug; 35(4):. doi: 10.23812/21-126-l. [PMID: 34278773]
  • Karthik Rajendran, Bhadram Kalyan Chekraverthy, Rajendran Sankham Devendran, R Jasmin Sajini, Krishnaveni Nagappan. Simultaneous quantification of oxcarbazepine and its active metabolite in spiked human plasma using ultra performance liquid chromatography-MS/MS. Bioanalysis. 2021 Aug; 13(16):1259-1273. doi: 10.4155/bio-2021-0125. [PMID: 34463119]
  • Ting Zhao, Lu-Hai Yu, Ting-Ting Wang, Jie Feng, Long Ma, Jing Yu, Li Sun, Hong-Jian Li, Yan Sun. Development and validation of an innovative UPLC method to quantify lacosamide, oxcarbazepine, and lamotrigine in the serum of children with epilepsy in China. Biomedical chromatography : BMC. 2021 Apr; 35(4):e5022. doi: 10.1002/bmc.5022. [PMID: 33169403]
  • Yoonhyuk Jang, Seonghae Yoon, Tae-Joon Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, Kon Chu, Sang Kun Lee. Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy. Scientific reports. 2021 03; 11(1):6370. doi: 10.1038/s41598-021-85920-0. [PMID: 33737678]
  • Bahareh Michelle Schweiger, Aaron-James Lao, Jane Tavyev. A Case Series of Patients With Central Hypothyroidism From Oxcarbazepine Therapy. Journal of child neurology. 2021 03; 36(3):237-242. doi: 10.1177/0883073820962926. [PMID: 33030389]
  • Reem Odi, Valentina Franco, Emilio Perucca, Meir Bialer. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe. Epilepsia. 2021 02; 62(2):285-302. doi: 10.1111/epi.16802. [PMID: 33426641]
  • Kai-Li Shi, Jun-Xiu Guo, Hui-Min Zhao, Han Hong, Chuan-Zi Yang, Yun-Hong Wu, Li-Jun Du. The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study. Epilepsy & behavior : E&B. 2020 12; 113(?):107555. doi: 10.1016/j.yebeh.2020.107555. [PMID: 33242769]
  • Sheng Feng, Brandi Bridgewater, Erin C Strickland, Gregory McIntire. A Rapid LC-MS-MS Method for the Quantitation of Antiepileptic Drugs in Urine. Journal of analytical toxicology. 2020 Oct; 44(7):688-696. doi: 10.1093/jat/bkaa095. [PMID: 32744607]
  • Elif Söylemez, Oya Öztürk, Sezin Alpaydın Baslo, Zeynep Ezgi Balçık, Dilek Ataklı. Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy. Epilepsy & behavior : E&B. 2020 10; 111(?):107296. doi: 10.1016/j.yebeh.2020.107296. [PMID: 32769040]
  • Sezin Erarpat, Süleyman Bodur, Merve Fırat Ayyıldız, Ömer Tahir Günkara, Fatih Erulaş, Dotse Selali Chormey, Fatma Turak, Türkan Börklü Budak, Sezgin Bakırdere. Accurate and simple determination of oxcarbazepine in human plasma and urine samples using switchable-hydrophilicity solvent in GC-MS. Biomedical chromatography : BMC. 2020 Oct; 34(10):e4915. doi: 10.1002/bmc.4915. [PMID: 32529647]
  • M Ley, A Principe, R Rocamora. [Long-term effects of dibenzazepines on metabolic parameters: retrospective comparison of carbamazepine, oxcarbazepine and eslicarbazepine acetate in the real world]. Revista de neurologia. 2020 Jul; 71(2):54-60. doi: 10.33588/rn.7102.2019207. [PMID: 32627160]
  • Anne Hagemann, Dennis Klimpel, Christian G Bien, Christian Brandt, Theodor W May. Influence of dose and antiepileptic comedication on brivaracetam serum concentrations in patients with epilepsy. Epilepsia. 2020 05; 61(5):e43-e48. doi: 10.1111/epi.16500. [PMID: 32304097]
  • Fanny Desbiolles, Xavier Moreau, Laetitia de Jong, Laure Malleret, Quentin Grandet-Marchant, Pascal Wong-Wah-Chung, Isabelle Laffont-Schwob. Advances and limits of two model species for ecotoxicological assessment of carbamazepine, two by-products and their mixture at environmental level in freshwater. Water research. 2020 Feb; 169(?):115267. doi: 10.1016/j.watres.2019.115267. [PMID: 31731244]
  • Shuzhang Zhang, Zhiping Zhang, Yuan Shen, Yudan Zhu, Kun Du, Jingkang Guo, Yonghua Ji, Jie Tao. SCN9A Epileptic Encephalopathy Mutations Display a Gain-of-function Phenotype and Distinct Sensitivity to Oxcarbazepine. Neuroscience bulletin. 2020 Jan; 36(1):11-24. doi: 10.1007/s12264-019-00413-5. [PMID: 31372899]
  • Katarzyna Socała, Elżbieta Wyska, Małgorzata Szafarz, Dorota Nieoczym, Piotr Wlaź. Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies. Neuropharmacology. 2019 11; 158(?):107733. doi: 10.1016/j.neuropharm.2019.107733. [PMID: 31377197]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Lihua Qu, Lixuan Pan, Li Wang, Congmin Liu, Yanhong Tian, Zhihui Hao. Development of an online solid-phase extraction-liquid chromatography-mass spectrometric analysis of oxcarbazepine and its active metabolite licarbazepine from plasma with a direct injection step. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2019 Sep; 1125(?):121710. doi: 10.1016/j.jchromb.2019.06.037. [PMID: 31299362]
  • Ekram Nemr Abd-Al-Haleem, Shaimaa Salah Eldeen-Hussein, Hanan Abdel-Hameed Fahmy, Ragia Ali Mahmoud-Taha. Effect of gamma radiation on combination therapy of certain antiepileptic drugs in rats. Pakistan journal of pharmaceutical sciences. 2019 Jul; 32(4):1589-1597. doi: . [PMID: 31608878]
  • Manhua Liu, Yangyang Wang, Yueping Jiang, Haitao Liu, Jingjing Chen, Shao Liu. Quantitation of Oxcarbazepine Clinically in Plasma Using Surfaced-Enhanced Raman Spectroscopy (SERS) Coupled with Chemometrics. Applied spectroscopy. 2019 Jul; 73(7):801-809. doi: 10.1177/0003702819845389. [PMID: 30990054]
  • Michele Fabrazzo, Antonietta Fuschillo, Francesco Perris, Francesco Catapano. The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series. International clinical psychopharmacology. 2019 07; 34(4):206-210. doi: 10.1097/yic.0000000000000265. [PMID: 30998596]
  • Chao-Yang Chen, Ying Zhou, Yi-Min Cui, Ting Yang, Xia Zhao, Ye Wu. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy. Journal of clinical pharmacy and therapeutics. 2019 Apr; 44(2):300-311. doi: 10.1111/jcpt.12792. [PMID: 30636182]
  • Xue Yang, Yuanliang Yan, Shu Fang, Shuangshuang Zeng, Hongying Ma, Long Qian, Xi Chen, Jie Wei, Zhicheng Gong, Zhijie Xu. Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms. Medicine. 2019 Mar; 98(12):e14908. doi: 10.1097/md.0000000000014908. [PMID: 30896644]
  • Xiaonian Han, Jing Huang, Jianhua Lv, Li Ma, Lirong Peng, Jinping Wang, Xiaojing Nie, Li Xia, Xin Zan. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy. PloS one. 2019; 14(1):e0210600. doi: 10.1371/journal.pone.0210600. [PMID: 30645607]
  • Yanan Chen, Shansen Xu, Zhanyou Wang, Mingming Zhao, Huanxin Wang, Tong Lu, Limei Zhao. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy. Therapeutic drug monitoring. 2018 12; 40(6):730-737. doi: 10.1097/ftd.0000000000000563. [PMID: 30169477]
  • Rituparna Maiti, Biswa Ranjan Mishra, Monalisa Jena, Archana Mishra, Santanu Nath, Anand Srinivasan. Effect of anti-seizure drugs on serum S100B in patients with focal seizure: a randomized controlled trial. Journal of neurology. 2018 Nov; 265(11):2594-2601. doi: 10.1007/s00415-018-9026-1. [PMID: 30173303]
  • Yuji Mano. LC-MS-MS Determination of Oxcarbazepine and an Active Metabolite in Human Plasma for Clinical Application. Journal of chromatographic science. 2018 Sep; 56(8):687-694. doi: 10.1093/chromsci/bmy040. [PMID: 29733349]
  • Michael J Palte, Sankha S Basu, Jameson L Dahlin, Ralitsa Gencheva, Donald Mason, Petr Jarolim, Athena K Petrides. Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Concurrent Measurement of Gabapentin, Lamotrigine, Levetiracetam, Monohydroxy Derivative of Oxcarbazepine, and Zonisamide Concentrations in Serum in a Clinical Setting. Therapeutic drug monitoring. 2018 08; 40(4):469-476. doi: 10.1097/ftd.0000000000000516. [PMID: 29994986]
  • Ian R McGrane, Joshua G Loveland, Jose de Leon. Possible Oxcarbazepine Inductive Effects on Aripiprazole Metabolism: A Case Report. Journal of pharmacy practice. 2018 Jun; 31(3):361-363. doi: 10.1177/0897190017710523. [PMID: 28539103]
  • Natalícia de Jesus Antunes, Lauro Wichert-Ana, Eduardo Barbosa Coelho, Oscar Della Pasqua, Veriano Alexandre Junior, Osvaldo Massaiti Takayanagui, Maria Paula Marques, Vera Lucia Lanchote. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of pharmaceutical and biomedical analysis. 2018 Feb; 149(?):442-447. doi: 10.1016/j.jpba.2017.11.041. [PMID: 29169112]
  • Rita Moretti, Paola Caruso, Matteo Dal Ben, Silvia Gazzin, Claudio Tiribelli. Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control. BMC gastroenterology. 2018 Jan; 18(1):19. doi: 10.1186/s12876-018-0751-9. [PMID: 29370761]
  • Christelle Rodrigues, Catherine Chiron, Elisabeth Rey, Olivier Dulac, Emmanuelle Comets, Gérard Pons, Vincent Jullien. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children. British journal of clinical pharmacology. 2017 12; 83(12):2695-2708. doi: 10.1111/bcp.13392. [PMID: 28771787]
  • Rituparna Maiti, Biswa Ranjan Mishra, Soham Sanyal, Debadatta Mohapatra, Sansita Parida, Archana Mishra. Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial. Epilepsy research. 2017 12; 138(?):5-10. doi: 10.1016/j.eplepsyres.2017.10.003. [PMID: 29028517]
  • Monica Puligheddu, Miriam Melis, Giuliano Pillolla, Giulia Milioli, Liborio Parrino, Giovanni Mario Terzano, Sonia Aroni, Claudia Sagheddu, Francesco Marrosu, Marco Pistis, Anna Lisa Muntoni. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. 2017 10; 58(10):1762-1770. doi: 10.1111/epi.13863. [PMID: 28766701]
  • Chunhong Shen, Bijun Zhang, Zhirong Liu, Yelei Tang, Yinxi Zhang, Shan Wang, Yi Guo, Yao Ding, Shuang Wang, Meiping Ding. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy. Seizure. 2017 Oct; 51(?):102-106. doi: 10.1016/j.seizure.2017.07.015. [PMID: 28837897]
  • Elias Begas, Andreas Tsakalof, Efthimios Dardiotis, Georgios Emmanouil Vatidis, Evangelos Kouvaras, Eftihia Konstadinos Asprodini. Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment. Biomedical chromatography : BMC. 2017 Sep; 31(9):. doi: 10.1002/bmc.3950. [PMID: 28182284]
  • Ana Ferreira, Márcio Rodrigues, Alexandre Marques, Amílcar Falcão, Gilberto Alves. Influence of the dual combination of silymarin and (-)-epigallocatechin gallate, natural dietary flavonoids, on the pharmacokinetics of oxcarbazepine in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2017 Aug; 106(Pt A):446-454. doi: 10.1016/j.fct.2017.06.015. [PMID: 28602600]
  • Bianca Berghuis, Job van der Palen, Gerrit-Jan de Haan, Dick Lindhout, Bobby P C Koeleman, Josemir W Sander. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia. 2017 07; 58(7):1227-1233. doi: 10.1111/epi.13777. [PMID: 28542738]
  • Elena Brezina, Carsten Prasse, Johannes Meyer, Harald Mückter, Thomas A Ternes. Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle. Environmental pollution (Barking, Essex : 1987). 2017 Jun; 225(?):261-269. doi: 10.1016/j.envpol.2016.10.106. [PMID: 28408188]
  • Yao Lu, Youxin Fang, Xunyi Wu, Chunlai Ma, Yue Wang, Lan Xu. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy. European journal of clinical pharmacology. 2017 Mar; 73(3):307-315. doi: 10.1007/s00228-016-2157-3. [PMID: 27900402]
  • Shahabeddin Rezaei, Sakineh Shab-Bidar, Ahmed Abdulahi Abdurahman, Kurosh Djafarian. Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis. Seizure. 2017 Feb; 45(?):87-94. doi: 10.1016/j.seizure.2016.11.016. [PMID: 27978484]
  • Mirosław Zagaja, Marta Andres-Mach, Paweł Patrzylas, Daniel Pyrka, Monika Szpringer, Magdalena Florek-Łuszczki, Dorota Żółkowska, Krystyna Skalicka-Woźniak, Jarogniew J Łuszczki. Influence of xanthotoxin (8-methoxypsoralen) on the anticonvulsant activity of various novel antiepileptic drugs against maximal electroshock-induced seizures in mice. Fitoterapia. 2016 Dec; 115(?):86-91. doi: 10.1016/j.fitote.2016.09.020. [PMID: 27702668]
  • Fawzia A Ibrahim, Amira F El-Yazbi, Magda A Barary, Mira M Wagih. Sensitive inexpensive HPLC determination of four antiepileptic drugs in human plasma: application to PK studies. Bioanalysis. 2016 Nov; 8(21):2219-2234. doi: 10.4155/bio-2016-0211. [PMID: 27678163]
  • Yunli Yu, Quanying Zhang, Wenjun Xu, Chengzhe Lv, Gang Hao. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy. European journal of drug metabolism and pharmacokinetics. 2016 Aug; 41(4):345-51. doi: 10.1007/s13318-015-0266-5. [PMID: 25700977]
  • Rui-Rui Li, Xiao-Yan Sheng, Ling-Yue Ma, Hong-Xin Yao, Li-Xin Cai, Chao-Yang Chen, Sai-Nan Zhu, Ying Zhou, Ye Wu, Yi-Min Cui. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy. Therapeutic drug monitoring. 2016 06; 38(3):365-70. doi: 10.1097/ftd.0000000000000278. [PMID: 26818624]
  • Chien-Ming Lin, Hueng-Chuen Fan, Tsu-Yi Chao, Der-Ming Chu, Chi-Chieh Lai, Chih-Chien Wang, Shyi-Jou Chen. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience. BMC pediatrics. 2016 05; 16(?):61. doi: 10.1186/s12887-016-0597-7. [PMID: 27142370]
  • Zhichao Yang, Xueyu Xu, Lingxia Sun, Xue Zhao, Hao Wang, John Paul Fawcett, Yan Yang, Jingkai Gu. Development and validation of an enantioselective SFC-MS/MS method for simultaneous separation and quantification of oxcarbazepine and its chiral metabolites in beagle dog plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2016 May; 1020(?):36-42. doi: 10.1016/j.jchromb.2016.03.013. [PMID: 27003707]
  • Ghada M El-Zaafarany, Mahmoud E Soliman, Samar Mansour, Gehanne A S Awad. Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies. International journal of pharmaceutics. 2016 Apr; 503(1-2):127-40. doi: 10.1016/j.ijpharm.2016.02.038. [PMID: 26924357]
  • Eun-Kee Bae, Jongtae Lee, Jung-Won Shin, Jangsup Moon, Keon-Joo Lee, Yong-Won Shin, Tae-Joon Kim, Dongseong Shin, In-Jin Jang, Sang Kun Lee. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis. Seizure. 2016 Apr; 37(?):8-12. doi: 10.1016/j.seizure.2016.02.002. [PMID: 26908152]
  • Xinxin Chen, Ermin Gu, Shuanghu Wang, Xiang Zheng, Mengchun Chen, Li Wang, Guoxin Hu, Jian-ping Cai, Hongyu Zhou. Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS. Journal of chromatographic science. 2016 Mar; 54(3):334-42. doi: 10.1093/chromsci/bmv146. [PMID: 26499119]
  • Natalícia de Jesus Antunes, Lauro Wichert-Ana, Eduardo Barbosa Coelho, Oscar Della Pasqua, Veriano Alexandre Junior, Osvaldo Massaiti Takayanagui, Eduardo Tozatto, Maria Paula Marques, Vera Lucia Lanchote. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European journal of clinical pharmacology. 2016 Feb; 72(2):195-201. doi: 10.1007/s00228-015-1970-4. [PMID: 26514967]
  • Chun-Yong Chen, Fang Xiao, Jing-Li Liu. Superficial siderosis of the central nervous system with seizures onset. Singapore medical journal. 2015 Oct; 56(10):590-1. doi: 10.11622/smedj.2015158. [PMID: 26512155]
  • M Ley, A Principe, J Jiménez-Conde, R Rocamora. Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests. Epilepsy research. 2015 Sep; 115(?):147-52. doi: 10.1016/j.eplepsyres.2015.06.013. [PMID: 26220393]
  • Annika Sattler, Marion Schaefer, Theodor W May. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy. Seizure. 2015 Sep; 31(?):149-54. doi: 10.1016/j.seizure.2015.07.018. [PMID: 26362393]
  • Xue-Mei Zou, Jia-Ni Chen, Dong-Mei An, Nan-Ya Hao, Zhen Hong, Xiao-Ting Hao, Ping Rao, Dong Zhou. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy. Seizure. 2015 Jul; 29(?):81-5. doi: 10.1016/j.seizure.2015.03.019. [PMID: 26076847]
  • Xue-Ping Zhu, Yao-Dong Zhao, Zhi Cheng, Ning Min Zhao, Hao Li. The establish of the HPLC method to examine the plasma concentration of lamotrigine and oxcarbazepine. Pakistan journal of pharmaceutical sciences. 2015 May; 28(3 Suppl):1121-5. doi: NULL. [PMID: 26051734]
  • Rosa Maria Paragliola, Alessandro Prete, Peter W Kaplan, Salvatore Maria Corsello, Roberto Salvatori. Treatment of hypopituitarism in patients receiving antiepileptic drugs. The lancet. Diabetes & endocrinology. 2015 Feb; 3(2):132-40. doi: 10.1016/s2213-8587(14)70081-6. [PMID: 24898833]
  • Ping Wang, Tao Yin, Hong-ying Ma, Dan-Qi Liu, Yangh-ao Sheng, Bo-Ting Zhou. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2015; 18(3):256-65. doi: . [PMID: 26517132]
  • Ana Ferreira, Márcio Rodrigues, Paula Oliveira, Joana Francisco, Ana Fortuna, Luísa Rosado, Pedro Rosado, Amílcar Falcão, Gilberto Alves. Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2014 Nov; 971(?):20-9. doi: 10.1016/j.jchromb.2014.09.010. [PMID: 25261836]
  • Shaza Deeb, Denise A McKeown, Hazel J Torrance, Fiona M Wylie, Barry K Logan, Karen S Scott. Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases. Journal of analytical toxicology. 2014 Oct; 38(8):485-94. doi: 10.1093/jat/bku070. [PMID: 25217536]
  • Yang Wang, Hua-nian Zhang, Chang-he Niu, Ping Gao, Yu-jun Chen, Jing Peng, Mao-chang Liu, Hua Xu. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy. Acta pharmacologica Sinica. 2014 Oct; 35(10):1342-50. doi: 10.1038/aps.2014.76. [PMID: 25220641]
  • Elena Kaiser, Carsten Prasse, Manfred Wagner, Kathrin Bröder, Thomas A Ternes. Transformation of oxcarbazepine and human metabolites of carbamazepine and oxcarbazepine in wastewater treatment and sand filters. Environmental science & technology. 2014 Sep; 48(17):10208-16. doi: 10.1021/es5024493. [PMID: 25137395]
  • Jing Peng, Hua-Nian Zhang, Zhi-Sheng Liu, Hua Xu, Yang Wang. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy. International journal of clinical pharmacology and therapeutics. 2014 Aug; 52(8):684-92. doi: 10.5414/cp202078. [PMID: 24887335]
  • Hélène Fenet, Lauren Arpin-Pont, Alice Vanhoutte-Brunier, Dominique Munaron, Annie Fiandrino, Maria-Jesus Martínez Bueno, Clotilde Boillot, Claude Casellas, Olivier Mathieu, Elena Gomez. Reducing PEC uncertainty in coastal zones: a case study on carbamazepine, oxcarbazepine and their metabolites. Environment international. 2014 Jul; 68(?):177-84. doi: 10.1016/j.envint.2014.03.025. [PMID: 24742703]
  • Lotte M Lang, Kristian Linnet. The ratio of 6β-hydroxycortisol to cortisol in urine as a measure of cytochrome P450 3A activity in postmortem cases. Journal of forensic sciences. 2014 Jul; 59(4):1036-40. doi: 10.1111/1556-4029.12418. [PMID: 24611975]
  • I Wegner, A J Wilhelm, D A J E Lambrechts, J W Sander, D Lindhout. Effect of oral contraceptives on lamotrigine levels depends on comedication. Acta neurologica Scandinavica. 2014 Jun; 129(6):393-8. doi: 10.1111/ane.12197. [PMID: 24571554]
  • J A French, P Baroldi, S T Brittain, J K Johnson. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial. Acta neurologica Scandinavica. 2014 Mar; 129(3):143-53. doi: 10.1111/ane.12207. [PMID: 24359313]
  • A Garoufi, E Koemtzidou, E Katsarou, A Dinopoulos, I Kalimeraki, A Fotinou, A Drakatos, A Attilakos. Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study. European journal of neurology. 2014; 21(1):118-23. doi: 10.1111/ene.12262. [PMID: 24118208]
  • Herng-Sheng Lee, Shih-Yu Wang, Donald M Salter, Chih-Chien Wang, Shyi-Jou Chen, Hueng-Chuen Fan. The impact of the use of antiepileptic drugs on the growth of children. BMC pediatrics. 2013 Dec; 13(?):211. doi: 10.1186/1471-2431-13-211. [PMID: 24354857]
  • Natalicia de Jesus Antunes, Lauro Wichert-Ana, Eduardo Barbosa Coelho, Oscar Della Pasqua, Veriano Alexandre, Osvaldo Massaiti Takayanagui, Eduardo Tozatto, Vera Lucia Lanchote. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study. Chirality. 2013 Dec; 25(12):897-903. doi: 10.1002/chir.22231. [PMID: 24123382]
  • Dong Wook Kim, Namyi Gu, Howard Lee, In-Jin Jang, Kon Chu, Kyung-Sang Yu, Joo-Youn Cho, Seo Hyun Yoon, Hyun Jeong Na, Sang Kun Lee. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. International journal of clinical pharmacology and therapeutics. 2013 Oct; 51(10):780-6. doi: 10.5414/cp201896. [PMID: 23849326]
  • Sebastian Bauer, Lorenz C Hofbauer, Martina Rauner, Adam Strzelczyk, Christoph Kellinghaus, Susanne Hallmeyer-Elgner, Wolfgang H Oertel, Felix Rosenow. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. Epilepsy research. 2013 Oct; 106(3):417-22. doi: 10.1016/j.eplepsyres.2013.06.020. [PMID: 23916144]
  • Christian Elger, Meir Bialer, Amílcar Falcão, Manuel Vaz-da-Silva, Teresa Nunes, Luís Almeida, Patrício Soares-da-Silva. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers. Epilepsia. 2013 Aug; 54(8):1453-61. doi: 10.1111/epi.12242. [PMID: 23758485]
  • Hamdi Cihan Emeksiz, Ayse Serdaroglu, Gürsel Biberoglu, Ozlem Gulbahar, Ebru Arhan, Ali Cansu, Mustafa Arga, Alev Hasanoglu. Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. Seizure. 2013 Mar; 22(2):124-7. doi: 10.1016/j.seizure.2012.11.007. [PMID: 23266348]
  • Krzysztof Łukawski, Tomasz Jakubus, Agnieszka Janowska, Grzegorz Raszewski, Stanisław J Czuczwar. Enalapril enhances the anticonvulsant activity of lamotrigine in the test of maximal electroshock. Pharmacological reports : PR. 2013; 65(4):1012-7. doi: 10.1016/s1734-1140(13)71083-1. [PMID: 24145096]
  • Susheela Rani, Ashok Kumar Malik. A novel microextraction by packed sorbent-gas chromatography procedure for the simultaneous analysis of antiepileptic drugs in human plasma and urine. Journal of separation science. 2012 Nov; 35(21):2970-7. doi: 10.1002/jssc.201200439. [PMID: 22997153]
  • Tore Haslemo, Kristine Olsen, Hilde Lunde, Espen Molden. Valproic Acid significantly lowers serum concentrations of olanzapine-an interaction effect comparable with smoking. Therapeutic drug monitoring. 2012 Oct; 34(5):512-7. doi: 10.1097/ftd.0b013e3182693d2a. [PMID: 22972535]
  • B J Steinhoff, H Stefan, A Schulze-Bonhage, R Hueber, W Paulus, M Wangemann, C E Elger. [Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study]. Der Nervenarzt. 2012 Oct; 83(10):1292-9. doi: 10.1007/s00115-012-3598-2. [PMID: 22850688]
  • Jill M Williams, Kunal K Gandhi, Shou-En Lu, Marc L Steinberg, Neal L Benowitz. Nicotine intake and smoking topography in smokers with bipolar disorder. Bipolar disorders. 2012 Sep; 14(6):618-27. doi: 10.1111/j.1399-5618.2012.01047.x. [PMID: 22938167]
  • Cecilie Johannessen Landmark, Arton Baftiu, Irene Tysse, Beate Valsø, Pål G Larsson, Elisif Rytter, Svein I Johannessen. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Therapeutic drug monitoring. 2012 Aug; 34(4):440-5. doi: 10.1097/ftd.0b013e31825ee389. [PMID: 22777154]
  • Martin Letmaier, Annamaria Painold, Anna Katharina Holl, Hartmut Vergin, Rolf Engel, Anastasios Konstantinidis, Siegfried Kasper, Renate Grohmann. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. The international journal of neuropsychopharmacology. 2012 Jul; 15(6):739-48. doi: 10.1017/s1461145711001192. [PMID: 21777511]
  • Meir Bialer, Patricio Soares-da-Silva. Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia. 2012 Jun; 53(6):935-46. doi: 10.1111/j.1528-1167.2012.03519.x. [PMID: 22612290]
  • Seyfettin Uludag, Yavuz Aydin, Ozlem Yilmaz, Figen Aksoy, Dogu Bakkaloglu, Cihat Sen. Multiple fetal anomalies in association with topiramate and oxcarbezepine treatment. Fetal and pediatric pathology. 2012 Jun; 31(3):154-8. doi: 10.3109/15513815.2012.659378. [PMID: 22413958]
  • Victor Biton. Lacosamide for the treatment of partial-onset seizures. Expert review of neurotherapeutics. 2012 Jun; 12(6):645-55. doi: 10.1586/ern.12.50. [PMID: 22650166]
  • Mehdi Esfandyari-Manesh, Mehran Javanbakht, Rassoul Dinarvand, Fatemeh Atyabi. Molecularly imprinted nanoparticles prepared by miniemulsion polymerization as selective receptors and new carriers for the sustained release of carbamazepine. Journal of materials science. Materials in medicine. 2012 Apr; 23(4):963-72. doi: 10.1007/s10856-012-4565-y. [PMID: 22331374]
  • Uluç Yiş, Mustafa Doğan. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Brain & development. 2012 Mar; 34(3):185-8. doi: 10.1016/j.braindev.2011.05.009. [PMID: 21676567]
  • O Babacan, A Karaoglu, S Vurucu, E Yesilkaya, O Yesilyurt, T Cayci, M Gulgun, B Unay, R Akın, O Ozcan. May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism?. Journal of clinical neurology (Seoul, Korea). 2012 Mar; 8(1):65-8. doi: 10.3988/jcn.2012.8.1.65. [PMID: 22523515]
  • Ana Fortuna, Gilberto Alves, Anabela Almeida, Bruno Lopes, Amílcar Falcão, Patrício Soares-da-Silva. A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain. Biomedical chromatography : BMC. 2012 Mar; 26(3):384-92. doi: 10.1002/bmc.1670. [PMID: 21780155]
  • Susheela Rani, Ashok K Malik, Baldev Singh. Novel micro-extraction by packed sorbent procedure for the liquid chromatographic analysis of antiepileptic drugs in human plasma and urine. Journal of separation science. 2012 Feb; 35(3):359-66. doi: 10.1002/jssc.201100789. [PMID: 22258806]
  • Luana Lionetto, Barbara Casolla, Michele Cavallari, Paolo Tisei, Carla Buttinelli, Maurizio Simmaco. High-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of carbamazepine, oxcarbazepine, and their main metabolites in human serum. Therapeutic drug monitoring. 2012 Feb; 34(1):53-8. doi: 10.1097/ftd.0b013e3182425168. [PMID: 22210100]
  • Dong Wook Kim, Nami Gu, In-Jin Jang, Kon Chu, Kyung-Sang Yu, Joo-Youn Cho, Seo Hyun Yoon, Hwa Suk Kim, Jeeyoung Oh, Sang Kun Lee. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy. Epilepsia. 2012 Jan; 53(1):e9-12. doi: 10.1111/j.1528-1167.2011.03318.x. [PMID: 22091603]
  • Kyoung-Jin Park, Jung-Ryul Kim, Eun Yeon Joo, Dae Won Seo, Seung Bong Hong, Jae-Wook Ko, Suk-Ran Kim, Wooseong Huh, Soo-Youn Lee. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy. Clinical neuropharmacology. 2012 Jan; 35(1):40-4. doi: 10.1097/wnf.0b013e31824150a5. [PMID: 22246398]
  • Slobodan M Jankovic, Milivoje Dostic. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. Expert opinion on drug metabolism & toxicology. 2012 Jan; 8(1):81-91. doi: 10.1517/17425255.2012.645535. [PMID: 22175232]
  • Ali Cansu, Ediz Yesilkaya, Ayse Serdaroglu, Orhun Camurdan, Tugba Luleci Hirfanoglu, Abdulbaki Karaoglu, Aysun Bideci, Peyami Cinaz. The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy. Endocrine research. 2012; 37(4):163-74. doi: 10.3109/07435800.2012.662663. [PMID: 22630163]
  • Kwon-Bok Kim, Kyung-Ah Seo, Sung-Eun Kim, Soo Kyung Bae, Dong-Hyun Kim, Jae-Gook Shin. Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis. 2011 Dec; 56(4):771-7. doi: 10.1016/j.jpba.2011.07.019. [PMID: 21840666]